&nbsp;

OBSP_en-24-5-18.html

May 2018

Document

OBSP_en-24-5-18.html

May 2018

Regimen

CHOP

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Curative

Funding:

ODB - General Benefit

prednisone

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2018

Regimen

CRBPPEME+BEVA

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Drugs Used:

pemetrexed,

CARBOplatin,

bevacizumab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

CISPPEME(RT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Curative, Adjuvant

Drugs Used:

pemetrexed,

CISplatin

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2019

Regimen

CISPPEME+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2022

Regimen

CRBPPEME+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2022

Document

OCSPInvitationSample-FR.pdf

May 2018

Document

OCSPInvitationSample.pdf

May 2018

Document

obsp-66-18.html

Jun 2018

Document

obsp-6-22-18.html

Jun 2018

Document